Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 1,588,000 | 1,437,000 | 1,322,000 | 1,398,000 | 1,383,000 |
| Cost of Goods | 1,150,000 | 1,081,000 | 1,030,000 | 1,056,000 | 1,116,000 |
| Gross Profit | 438,000 | 356,000 | 292,000 | 342,000 | 267,000 |
| Operating Expenses | 191,000 | 181,000 | 539,000 | 227,000 | 258,000 |
| Operating Income | 247,000 | 175,000 | -247,000 | 115,000 | 9,000 |
| Interest Expense | 54,000 | 51,000 | 61,000 | 51,000 | 50,000 |
| Other Income | 32,000 | 49,000 | 34,000 | 170,000 | 0 |
| Pre-tax Income | 225,000 | 173,000 | -274,000 | 234,000 | -41,000 |
| Income Tax | 64,000 | 22,000 | -44,000 | 30,000 | -23,000 |
| Net Income Continuous | 161,000 | 151,000 | -230,000 | 204,000 | -18,000 |
| Minority Interests | N/A | 1,000 | N/A | N/A | N/A |
| Net Income | $161,000 | $150,000 | $-230,000 | $204,000 | $-18,000 |
| EPS Basic Total Ops | 0.87 | 0.82 | -1.26 | 1.12 | -0.10 |
| EPS Basic Continuous Ops | 0.87 | 0.82 | -1.27 | 1.12 | -0.10 |
| EPS Diluted Total Ops | 0.84 | 0.79 | -1.25 | 1.11 | -0.10 |
| EPS Diluted Continuous Ops | 0.84 | 0.80 | -1.26 | 1.11 | -0.10 |
| EBITDA(a) | $322,000 | $249,000 | $-174,000 | $192,000 | $85,000 |